-
Sep 2017 Quarterly Result AnnouncedSep 2017 Sales EBITDA PAT EPS Amount 3,074 Cr 1,039 Cr 753 Cr 12.8 Rs Growth 18.6% 11.8% 24.3% 23.6% -
Replied on AUROPHARMA 's post
| Sep 2017 | Sales | EBITDA | PAT | EPS |
| Amount | 3,074 Cr | 1,039 Cr | 753 Cr | 12.8 Rs |
| Growth | 18.6% | 11.8% | 24.3% | 23.6% |
